CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
9 research outputs found
Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction
Author
DAKLINZA
DAKLINZA
+12 more
EPCLUSA
EPCLUSA
HARVONI
HARVONI
OLYSIO
OLYSIO
SOVALDI
SOVALDI
VIEKIRA PAK
VIEKIRA PAK
ZEPATIER
ZEPATIER
Publication venue
'Walter de Gruyter GmbH'
Publication date
Field of study
No full text
Crossref
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
Author
Gane EJ
Harvoni (ledipasvir‐sofosbuvir) tablets
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
No Pharmacokinetic Interaction Between the Hepatitis C Virus Inhibitors Elbasvir/Grazoprevir and Famotidine or Pantoprazole
Author
AASLD/IDSA HCV Guidance Panel
Buti
+16 more
Coburn
EPCLUSA
Forns
Harper
HARVONI
Lauffenburger
Mohd Hanafiah
Ogawa
PEPCID
Reau
Rockstroh
Roth
Summa
ZEPATIER
ZEPATIER
Zeuzem
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Successes and Challenges on the Road to Cure Hepatitis C
Author
AYM Howe
C Moreno
+21 more
DB Smith
DR Nelson
H Kumada
Harvoni
JG McHutchison
K Mohd Hanafiah
L Rong
M Manns
MS Sulkowski
MS Sulkowski
O Falkowski
Olysio
R Lozano
Richard C. Condit
RT Chung
Sovaldi
Stacy M. Horner
Susanna Naggie
V Lo Re
V Mallet
Viekira Pak
Publication venue
'Public Library of Science (PLoS)'
Publication date
Field of study
No full text
Crossref
Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD Study
Author
Aghemo
Akiyama
+43 more
Alimohammadi
Beck
Benhammou
Bonacini
Centers for Disease Control and Prevention.
Centers for Disease Control and Prevention.
Chromy
Coffin
Cunningham
Cunningham
Cunningham
Darvishian
Dore
Elion
Falade-Nwulia
Foster
Gilead Sciences Inc.
Gowda
Grebely
Grebely
Harvoni [package insert].
Jacobson
Kramer
Leo
Litwin
Litwin
Martin
Martinello
Mason
Naggie
Petersen
Platt
Rockstroh
Rosenthal
Schmidbauer
Serper
Su
Sulkowski
The Lancet Gastroenterology Hepatology.
Townsend
Wade
Ward
World Health Organization
Publication venue
'Oxford University Press (OUP)'
Publication date
Field of study
No full text
Crossref
An endogenous explanation of growth: direct-to-consumer stem cell therapies in PR China, India and the USA
Author
Abbott A
Bersenev A
+32 more
Charitou CD
Christensen C
EMA
EPAR-ChondroCelect
EPAR-Glybera. Glybera
EPAR-Holoclar. Holoclar
EPAR-Holoclar. Holoclar
EPAR-Imlygic. Imlygic
EPAR-MACI. MACI
EPAR-Provenge. Provenge
EPAR-Strimvelis. Strimvelis
Griffin. Fibrocell Science Inc.
Harvoni
Hiltzik M
Humira
Mendick R
Mulin E
NICE
NICE
NICE
NICE
Pfizer
Regalado A
Saheli Datta
Schlatter S
Schoenberger CR
The Hindu
The Hindu
The Hindu
Thomas GS
Webster A
Weintraub A
Publication venue
'Future Medicine Ltd'
Publication date
Field of study
No full text
Crossref
Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation
Author
Afdhal
Agarwal
+55 more
Back
Backus
Badri
Bhamidimarri
Bourliere
Bourliere
Bristol-Myers Squibb
Charlton
Colombo
Curry
Desnoyer
Durand
Echeverria
EPCLUSA
Fabrizi
Fernandez
Fissell
Foster
Gane
Gane
Gane
Goldberg
Goossens
Gordon
HARVONI
Jacobson
Jain
Jansenn Therapeutics
Kamar
Kanwal
Kidney Disease: Improving Global Outcomes
Kirby
Kwo
Loustaud-Ratti
Mahmoud
Manns
Mauss
Mavyret
Merck & Co. Inc
Mohd Hanafiah
Molnar
Nazario
Penin
Pockros
Polaris Observatory HCVC
Poordad
Poordad
Reau
Roth
Sawinski
Saxena
Sise
Ueda
VIEKIRA XR
Wei
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials
Author
Backus
Backus
+38 more
Backus
Bhattacharya
Burton
Centers for Disease Control and Prevention
Chen
Chung
Collins
Daklinza (package insert)
Edlin
Epclusa (package insert)
Falade-Nwulia
Falade-Nwulia
Ge
Harvoni (package insert)
Incivek® (package insert)
Kirk
Lo Re
Mavyret (package insert)
Naggie
Olysio (package insert)
O’Brien
Patel
Platt
Reddy
Sikavi
Struble
Su
Sulkowski
van der Meer
Victrelis® (package insert)
Viekira Pak (package insert)
Vosevi (package insert)
Wilder
Wilder
World Health Organization (WHO)
Wyles
Wyles
Zepatier (package insert)
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial
Author
Ampuero
Asselah
+42 more
Catherine A.M. Stedman
Cento
Curry
David Bernstein
David Pound
Diana M. Brainard
Edward J. Gane
European Association for Study of Liver
Feld
Foster
Gane
Gower
Gregory Everson
Hadas Dvory-Sobol
Harvoni (ledipasvir-sofosbuvir) tablets
Jenny C. Yang
John E. Poulos
John G. McHutchison
Kimberly Beavers
Kirby
Kohli
Kohli
Kris V. Kowdley
Kyle Etzkorn
Lawitz
Lawitz
Luisa M. Stamm
Maribel Rodriguez-Torres
Messina
Mindie H. Nguyen
Mitchell Davis
Mohd Hanafiah
Myron Tong
Naoky Tsai
Omer Khalid
Paul Y. Kwo
Raymond T. Chung
Rodriguez-Torres
Sophia Lu
Sovaldi (sofosbuvir)
Stuart C. Gordon
Taylor
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref